<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03411460</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2016/MR-01</org_study_id>
    <nct_id>NCT03411460</nct_id>
  </id_info>
  <brief_title>Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System</brief_title>
  <acronym>GLUCO FLASH</acronym>
  <official_title>Satisfaction of Using a Continuous Glucose Monitoring System to Monitor Interstitial Fluid Glucose Level in Hospitalized Insulin-dependent Diabetic Patients Treated Using a Portable Sub-cutaneous Pump</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to establish whether routine usage of the FreeStyle Libre™ system
      (Abbott) improves satisfaction and quality of sleep in patients hospitalized for poor
      glycemic control with an indication for external insulin pump treatment.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    logistical difficulties
  </why_stopped>
  <start_date type="Actual">April 19, 2017</start_date>
  <completion_date type="Actual">August 23, 2017</completion_date>
  <primary_completion_date type="Actual">August 23, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction of patient-determined hospital care at discharge in the two groups</measure>
    <time_frame>at discharge from hospital; maximum Day 5</time_frame>
    <description>visual analogue scale 0-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction concerning treatment for their diabetes</measure>
    <time_frame>at discharge from hospital; maximum Day 5</time_frame>
    <description>Diabetes Treatment Satisfaction Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient quality of sleep</measure>
    <time_frame>at each day of hospitalization and discharge; maximum Day 5</time_frame>
    <description>Spiegel questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of nursing staff concerning care of patient</measure>
    <time_frame>at end of study; maximum Day 5</time_frame>
    <description>visual analogue scale response to 5 quesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time taken by nurse to measure circulating glucose level</measure>
    <time_frame>Daily over length of hospitalization until maximum Day 5</time_frame>
    <description>in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time necessary to achieve satisfactory equilibrium using insulin pump</measure>
    <time_frame>maximum Day 5</time_frame>
    <description>average daily glucose level &lt; 1.50 g/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of glucose readings above 2g/l and below 0.80g/l over the hospital stay</measure>
    <time_frame>maximum Day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hypoglycmic events with the corresponding glucose level</measure>
    <time_frame>maximum Day 5</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Insulin-Dependent Diabetes</condition>
  <arm_group>
    <arm_group_label>Interstitial glucose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Glucose level tested by continuous monitoring device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood glucose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Glucose level tested on glucose monitor using standard finger prick</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FreeStyle Libre™ system</intervention_name>
    <description>Measured non-invasively via scanner</description>
    <arm_group_label>Interstitial glucose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Finger prick</intervention_name>
    <description>Blood test</description>
    <arm_group_label>Blood glucose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has given their free and informed consent

          -  The patient must be insured or the beneficiary of an insurance policy

          -  The patient is aged at least 18 years and less than 75 years old.

          -  Patients have a BMI between 18 and 40kg/m2

          -  Diabetic patient admitted for glycemic instability with indication for treatment using
             an external insulin pump but otherwise in a stable clinical state

        Exclusion Criteria:

          -  The subject is participating in another study

          -  The subject is in an exclusion period determined by a previous study

          -  The patients is under judicial protection or state guardianship

          -  The subject refuses to sign the consent form

          -  It proves impossible to give the subject clear information.

          -  The patient is pregnant, parturient or breastfeeding

          -  The patient is clinically unstable

          -  BMI less than 18 or over 40

          -  Existence of a severe rapidly progressive ischemic retinopathy or proliferative
             retinopathy.

          -  Serious psychiatric problems

          -  Chronic cutaneous infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2017</study_first_submitted>
  <study_first_submitted_qc>January 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2018</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

